CAMP4 Therapeutics Corp
NASDAQ:CAMP
Cash Flow Statement
Cash Flow Statement
CAMP4 Therapeutics Corp
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
(52)
|
(64)
|
(52)
|
(53)
|
|
| Depreciation & Amortization |
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
4
|
3
|
4
|
4
|
|
| Other Non-Cash Items |
6
|
7
|
6
|
8
|
|
| Change in Working Capital |
(1)
|
(5)
|
(2)
|
(3)
|
|
| Cash from Operating Activities |
(46)
N/A
|
(60)
-32%
|
(46)
+24%
|
(48)
-5%
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(1)
-63%
|
(1)
+25%
|
(1)
+7%
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
76
|
76
|
76
|
109
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
(4)
|
(5)
|
(4)
|
12
|
|
| Cash from Financing Activities |
72
N/A
|
72
+0%
|
73
+2%
|
121
+66%
|
|
| Change in Cash | |||||
| Net Change in Cash |
26
N/A
|
11
-58%
|
27
+147%
|
72
+170%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
(46)
N/A
|
(61)
-33%
|
(46)
+24%
|
(48)
-5%
|
|